Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19
Jun‐Hyung Cho(Korea National Institute of Health), Jang‐Hoon Choi(Korea National Institute of Health)
Cited by 99
Related Papers
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|bioRxiv (Cold Spring Harbor Laboratory)|2022|10